Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Silvia Segovia Chacón"'
Autor:
Laura Pazzagli, Silvia Segovia Chacón, Christos Karampelias, Jacqueline M Cohen, Gabriella Bröms, Helle Kieler, Ingvild Odsbu, Randi Selmer, Olov Andersson, Carolyn E Cesta
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272046 (2022)
IntroductionInconsistent results have been reported on the association between folic acid use in pregnancy and risk of GDM. The aim of this study was to estimate the association between folic acid use and GDM in two population-based Nordic cohorts.Ma
Externí odkaz:
https://doaj.org/article/e08f10d0c08c4cf8b0e7a6ada4d6ef70
Autor:
Helena, Kopp-Kallner, Marie, Linder, Carolyn E, Cesta, Silvia, Segovia Chacón, Helle, Kieler, Sofie, Graner
Publikováno v:
Obstetrics and gynecology. 139(5)
To estimate the incidence rates for ectopic pregnancy by contraceptive method in a cohort of women using hormonal contraception in Sweden between 2005 and 2016.Women aged 15-49 years with a filled prescription for a hormonal contraceptive in the Swed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bff9083cd2836589e4c4f399fc79322f
https://pubmed.ncbi.nlm.nih.gov/35576335
https://pubmed.ncbi.nlm.nih.gov/35576335
Autor:
Pär Karlsson, Anne Broe, Kari Furu, Carolyn E. Cesta, Silvia Segovia Chacón, Anders Engeland, Per Damkier, Helle Kieler
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica
Cesta, C E, Segovia Chacón, S, Engeland, A, Broe, A, Damkier, P, Furu, K, Kieler, H & Karlsson, P 2021, ' Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia ', Acta Obstetricia et Gynecologica Scandinavica, vol. 100, no. 11, pp. 2111-2118 . https://doi.org/10.1111/aogs.14251
Cesta, C E, Segovia Chacón, S, Engeland, A, Broe, A, Damkier, P, Furu, K, Kieler, H & Karlsson, P 2021, ' Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia ', Acta Obstetricia et Gynecologica Scandinavica, vol. 100, no. 11, pp. 2111-2118 . https://doi.org/10.1111/aogs.14251
Introduction For phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, the only approved indication in women is for pulmonary arterial hypertension. These drugs are increasingly being proposed and tested for treatment of female infertility
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdbff5456b9069929f9a13ab28683d2b
https://hdl.handle.net/11250/2831774
https://hdl.handle.net/11250/2831774
